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The dentogingival junction is of crucial importance in periodontal host defense both structurally and functionally. Oral bacteria
exert a constant challenge to the host cells and tissues at the dentogingival junction. The host response is set up to eliminate the
pathogens by the innate and adaptive defense mechanisms. In health, the commensal bacteria and the host defense mechanisms are
in a dynamic steady state. During periodontal disease progression, the dental bacterial plaque, junctional epithelium (JE), inflam-
matory cells, connective tissue, and bone all go through a series of changes. The tissue homeostasis is turned into tissue destruction
and progression of periodontitis. The classical study of Slots showed that in the bacterial plaque, the most remarkable change is
the shift from gram-positive aerobic and facultatively anaerobic flora to a predominantly gram-negative and anaerobic flora. This
has been later confirmed by several other studies. Furthermore, not only the shift of the bacterial flora to a more pathogenic
one, but also bacterial growth as a biofilm on the tooth surface, allows the bacteria to communicate with each other and exert
their virulence aimed at favoring their growth. This paper focuses on host-bacteria crosstalk at the dentogingival junction and the
models studying it in vitro.
1. Microorganisms in Subgingival Biofilm
The presence of the initial colonizers on the tooth surface is
essential for the emergence of the gram-negative periodon-
topathogens Porphyromonas gingivalis, Tannerella forsythia
(Bacteroides forsythus), Aggregatibacter actinomycetemcomi-
tans, and Fusobacterium, Prevotella, Campylobacter, and Tre-
ponemaz species [1–3]. Recently also gram-positive genera
such as Peptostreptococcus and Filifactor have been suggested
to play roles in periodontitis [4]. The genera Megasphaera
and Desulfobulbus have also been found to be elevated in
periodontitis, even to a larger extent than species tradition-
ally implicated as periodontopathogens [4]. Recent studies
have also identified Staphylococcus aureus in pockets of the
majority (60,5%) of nonsmoking patients with aggressive
periodontitis [5]. In addition to known periodontal
pathogens, other bacterial species, such as Pseudoramibacter,
Bacteroidetes, Sphorocytophaga, Shuttleworthia, Dialister,
Mogibacterium, Mycoplasma, Synergistes, and Acidaminococ-
caceae, seem to exist at high levels in patients with refractory
nature of periodontitis [6].
Microorganisms other than bacteria have also been
found in periodontitis patients. Candida species have been
detected in 15–21% of periodontitis patients as well as in
healthy subjects [3, 7–9]. The coexistence of, for example,
Epstein-Barr and human cytomegalovirus together with
periodontopathogens has also been implicated to play a role
in periodontal pathogenesis [10].
Although novel detection methods have allowed the
recognition of new species that could be involved in the
pathogenesis of periodontitis, recent studies suggest that the
whole composition, rather than single species, influence the
pathogenicity of the biofilm [11, 12]. In addition to the pro-
tective structures of multispecies biofilm which inhibit the
actions of host defense cells, the molecular interactions bet-
ween diﬀerent species [13, 14] in the oral biofilm could
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influence the virulence of the bacterial community. Espe-
cially quorum sensing signal, autoinducer-2, is used in inter-
species signaling between various periodontal pathogens,
and it may enhance the formation of the biofilm as well
as change the virulence gene expression [15]. Moreover,
by weakening the host defense, opportunistic periodontal
pathogens, such as P. gingivalis, may allow the overgrowth of
commensal oral species which leads to detrimental inflam-
mation and periodontal bone loss [16].
2. The Junctional
Epithelium-Bacteria Interactions
The first line of innate host defense in the periodontal region
is the JE that hinders bacterial advancement into periodontal
tissues, Figure 1(a). JE is a unique epithelial structure firmly
attached to the hard tissue of tooth via hemidesmosomes.
The cells directly attached to the tooth, DAT-cells [17], have
been shown to be dividing cells like the basal cells. Rapid
renewal and constant shedding of the JE cells towards the sul-
cus together with the gingival crevicular fluid (GCF) flow are
eﬃcient inhibitors of bacterial colonization. This is further
strengthened by the external basal lamina (EBL) and internal
basal lamina (IBL) that function as barriers to bacterial
advancement, yet allowing the passage of leukocytes and
their antimicrobial agents and antibodies into the gingival
crevice. Interestingly the composition of the IBL and EBL
diﬀers from each other and also seems to diﬀer from the base-
ment membrane of the outer gingival epithelium, suggesting
a very diﬀerent role for these basement membranes [18].
Whereas the IBL is dedicated to maintain the attachment to
the tooth, the EBL functions merely as a protective barrier.
The JE cells actively facilitate leukocyte recruitment to the site
of inflammation by expressing chemotactic factors (IL-8
and complement C5a) and factors such as ICAM-1 that
aid leukocyte course from the blood vessels [19–22]. The
active role of the JE in the innate host defense is further
demonstrated by the production of cytokines and the
presence of natural antimicrobial peptides and proteins such
as the defensins, the cathelicidin family members (LL-37),
and calprotectin [23–25]. Human beta-defensins (hBDs)
are expressed in gingival epithelia, salivary glands, saliva,
and GCF [26–28] as a response to bacterial challenge [29–
31]. Calprotectin, expressed in neutrophils, monocytes, and
gingival keratinocytes, protects gingival keratinocytes against
binding and invasion by P. gingivalis [32]. Alpha-defensins
secreted by neutrophils are bound to junctional and pocket
epithelium serving as an additional antimicrobial function
[33]. It has been shown that JE cells lateral to DAT cells pro-
duce matrilysin (MMP-7) [34]. This enzyme is able to acti-
vate the precursor peptide of alpha-defensin, an important
antimicrobial agent of mucosal epithelium [35]. It is possible
that a similar active matrilysin/defensin system exists in JE,
as in other mucosa exposed to bacteria such as intestine and
lungs [36].
A prerequisite for the bacteria to “win the battle” and
gain more living space subgingivally appears to be degener-
ation of the DAT cells (Table 1). Alternatively, degradation
of IBL on the tooth surface and consequently detachment
of the JE takes place. A third possibility is bacterial invasion
into JE cells and formation of an intraepithelial split that then
results in periodontal pocket formation. These initial events
in periodontal tissue destruction/pocket formation are sur-
prisingly poorly known, Figure 1(b). Decreased mitosis and
increased apoptosis of gingival epithelial cells has been
shown at sites exhibiting severe inflammation [69]. Bacterial
internalization in a tissue culture model and in vivo in severe
periodontitis followed by epithelial cell apoptosis have also
been demonstrated [70, 71]. A simultaneous application of
LPS and proteases to rat gingiva has been found to cause
apoptosis of connective tissue and periodontal ligament
fibroblasts followed by apical migration of the JE [72].
During bacterial challenge the host cells recognize the
bacteria and diﬀerent antigens by diﬀerent receptors that
have been detected also on periodontal tissues. Toll-like
receptor-2 (TLR-2), that recognizes, for example, bacterial
peptidoglycans (PGN), lipoproteins, and LTAs has been
found in abundance in the membrane of pocket epithelial
cells as compared to the gingival tissues of healthy controls
[73]. Protease activated receptors (PARs) mediate cellular
responses to extracellular proteinases such as thrombin and
trypsin-like serine proteases. PARs are expressed in human
neutrophils, gingival fibroblasts, and osteoblasts [74, 75].
In vitro experiments have shown that P. gingivalis proteases
stimulate PARs also in oral epithelial cells leading to
proinflammatory cytokine IL-6 and IL-8 secretion [31, 76].
However, P. gingivalis may also have an opposite eﬀect, since
P. gingivalis invasion into epithelial cells has been shown to
block IL-8 production and thus it may aﬀect the chemotactic
IL-8 gradient in the JE. [77, 78] In vitro studies have
suggested that PAR-2 receptors expressed in gingival ker-
atinocytes may contribute to hBD expression when chal-
lenged by gingipains, TNF-alpha or IL-1beta [31]. However,
it seems that a certain threshold exists to inflammatory and
bacterial challenge and the expression of hBDs, since in
chronic (advanced) periodontitis the expression of hBDs-2
and -3 is reduced [28]. Application of PAR agonist peptide
to gingiva has induced periodontitis in rats (radiographically
assessed bone loss, myeloperoxidase (MPO) activity) [79].
Thus the activation of PARs seems to be important for the
protective host response at the periodontal region. Whether
modulation/activation/suppression of these cellular recep-
tors can be used in periodontal therapy remains to be
studied.
3. Connective Tissue (Fibroblasts andMMPs)
Response to Bacterial Challenge
Gingival CT is composed of extracellular matrix (ECM) and
fibroblasts producing the ECM and participating immune
and inflammatory responses of the gingiva. The ECM com-
prises of fibers (mainly collagen I), proteoglycans, glycopro-
teins and water. CT is constantly renewed and that requires
degradation of the ECM components, therefore gingival
fibroblasts also produce proteolytic enzymes, MMPs. The
MMPs are controlled by tissue inhibitors of MMPs (TIMPs)
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Table 1: Virulence factors of periodontopathogenic bacteria, and their eﬀects on host cells.
Bacterial virulence factor Eﬀect on host cells References
Fimbriae, flagellae
Promote bacterial colonization, adherence and invasion of host cells [37, 38]
Modulate inflammatory response
Lipoteichoic acids (LTAs)
Mediate bacterial adhesion to human cells and teeth
[39–47]
Arrest growth and decrease mitosis in epithelial cells
Stimulate leukocytes, activate complement
Increase cytokine and inflammatory mediator production
Stimulate bone resorption
Lipopolysaccharides (LPSs)
Increase epithelial cell permeability, penetrate gingival epithelium
[39, 45, 48–58]
Stimulate JE basal cell proliferation at high concentration (5000 μg/mL)
Stimulate gingival fibroblast proliferation at low concentration (<10 μg) and
suppress at high concentration
Stimulate T-helper cell proliferation
Increase cytokine and inflammatory mediator production
Activate osteoclasts
Short chain fatty acids (SCFAs)
Raise inflammatory response [59–63]
Inhibit gingival epithelial cell and fibroblast proliferation
Proteinases
Activate host MMP:s, degrade extracellular matrix components, immunoglobulins
and complement proteins
Promote apoptosis in gingival fibroblasts [64]
Induce human β-defensin-2 expression in gingival epithelial cells in vitro
Heat shock proteins
Activate epithelial cells and osteoclasts at low concentrations and cause cell death at
high concentrations
[65]
Cytolethal distending toxin Upregulate RANKL expression in T cells [66]
Leukotoxin Cause apoptosis and necrosis of PMNs, T cells, natural killer cells [48]
Capsule Increase resistance to phagocytosis [48]
Ammonium, hydrogen sulphide Toxic to cells, cause cell vacuolization, inhibit collagen formation [67, 68]
and in healthy periodontal tissue the TIMP levels exceed
MMP [80]. Bacteria at the gingival margin causes drastic
changes in CT; vascular permeability and the amount of
inflammatory cell infiltrate are increased. Fibroblast func-
tions are altered; cell proliferation and collagen production
are impaired and components of extracellular matrix are
degraded [81–84]. This is thought to result from both host-
and bacteria-derived agents, such as lipopolysaccharides
(LPSs), inflammatory cytokines, for example, IL-1beta, and
TNF-alpha and to a lesser extent also by IL-17, growth
factors and hormones [80, 85, 86] that activate leukocytes,
fibroblasts, and epithelial cells leading to production of
prostaglandins and MMPs and causing destruction of the
CT [72, 87, 88]. In addition to the activation of the latent
forms of MMPs, bacteria-derived proteinases may inactivate
proteinase inhibitors such as alpha-1-antitrypsin and alpha-
2-macroglobulin and thus result in higher levels of active
proteinases [89–92]. Increased amounts of MMP-1, -2, -3,
-8, -9, and -13 have been found in GCF and gingiva of peri-
odontitis patients compared with samples from healthy con-
trols [22, 85, 93–99]. Increased levels ofMMPs and decreased
amounts of their tissue inhibitors have been connected to
the progression of periodontal disease [100, 101]. The
destruction of CT in the periodontal region seems to
be the result of synergistic action of both bacteria and
host derived proteinases leading to an imbalance of the
proteinases over their inhibitors [80]. Furthermore, a recent
study on experimental periodontitis showed dual changes
in CT; simultaneous collagen fiber breakdown and fiber
bundle thickening, and suggested a protective role for
the inflammatory tissue breakdown in order to avoid the
spreading of the infection into the deeper areas [102].
4. Crosstalk between the Bacteria and
Polymorphonuclear-Leukocytes,
Complement andMacrophages
PMNs are the main leukocytes isolated from gingival crevice.
They are the first defense cells to respond to bacterial
stimulus and they are present within minutes after stimulus.
In the dentogingival area the bacteria are always present and
the migration of PMNs and macrophages/monocytes into
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the gingival crevice is continuous. Thus even clinically
healthy gingiva demonstrates some neutrophils in JE and the
underlying CT [103]. Neutrophils are viable and functional
in the gingival crevice. The “leukocyte wall” [104] is formed
by neutrophils between the plaque and the junctional and
sulcular epithelium. The leukocyte wall has proteolytic,
phagocytic, and antibacterial (MPO, defensins, and other
antibacterials such as lactoferrin) features. Although aimed
against the bacteria, PMN activation and especially prema-
ture release of their granule products such as proteolytic
enzymes and reactive oxygen species play a central role in
periodontal tissue destruction [105, 106]. PMNs are essential
in the first line of innate defense against plaque bacteria at
the gingival margin. When the PMNs come to contact with
the bacteria, they release their granular contents, adhere to
individual bacteria and attempt to phagocytose them. The
PMNs are a major contributor in the host parasite equilib-
rium but when activated can also cause tissue damage due to
excess of enzymes, reactive oxygen species, MMPs, and other
components that are released from their granules during the
battle against microbes [48, 107–111].
Proteases such as elastase, cathepsin G, and MMPs, of
which MMP-8, and MMP-9 are mainly originated from
neutrophils, are able to degrade a wide variety of host cellular
and extracellular components [112]. The fact, that when
MMP activity is inhibited, tissue destruction is reduced,
further emphasizes the role of MMPs on tissue destruction
[113].
The main role of PMNs, however is phagocytosis and
the PMNs in the gingival tissues are the main controllers of
the microbial ecology within the gingival crevice. The cross-
talk between neutrophils and immune cells is constant. Neu-
trophils have surface receptors for both complement (C5a-
receptor) and immunoglobulin (Fc gamma-receptors) and
the interaction with opsonized bacteria leads to phagocytosis
of the bacteria. However, some periodontopathogens may
escape PMN phagocytosis and even cause PMN death when
ingested. Complement mediated phagocytosis of A. actino-
mycetemcomitans has been found ineﬃcient regardless of the
strain serotype, the majority of ingested A. actinomycetem-
comitans staying viable. Furthermore, when opsonized with
antibody, A. actinomycetemcomitans has caused rapid death
of the PMNs [114]. Impaired PMN functions are generally
considered to be related to periodontal tissue destruction and
patients with reduced number of neutrophils or impaired
neutrophil function show often severe periodontitis [115].
Smoking also impairs neutrophil functions, for example,
phagocytosis [116]. However, some studies have indicated
that, in contrast to impaired function, PMN hyperreactivity
may play a role in periodontitis [117]. Increased oxygen rad-
ical and elastase release in response to bacterial stimulation
has been connected, for example, to Fc gamma polymor-
phism (receptor RIIa131H/H genotype) [118]. The innate
nature of PMN hyperresponsiveness is supported by a study
showing high levels of PMN oxygen radical production in
periodontitis patients also after periodontal treatment [27].
If the PMN dependent defense is insuﬃcient, the inflam-
mation is prolonged and lymphocytes, macrophages, and
plasma cells start to dominate the infiltrate. This leads to the
release of the proinflammatory cytokines (e.g., IL-1, IL-6, IL-
8, and TNF-alpha) and prostaglandins (e.g., PGE2), and the
adaptive immune response is set up. A shift in the balance
between anti-inflammatory and proinflammatory cytokines
may be crucial for the progression of periodontitis. TGF-beta
is an anti-inflammatory cytokine that also inhibits epithelial
cell proliferation. In healthy JE αvβ6 integrin activates the
latent TGF-beta. In inflamed pocket epithelium, however,
αvβ6 integrin is absent allowing high epithelial proliferation
[119].
The nonspecific innate immune system provides an
immediate response, recognizing the diﬀerence between
self-components and foreign molecules in the periodontal
region. The microbial recognition is based on interaction
between microbial ligands known as pathogen-associated
molecular patterns (PAMPs) (e.g., LPS, LTA, peptidoglycan
(PGN), and fimbriae) and pattern-recognition receptors
(PRRs) of host. Host PRRs may be either soluble (e.g.,
complement), membrane-bound (like TLRs, on the cells
involved in immune response), or cytosolic (like nucleotide-
binding oligomerization domain proteins, Nods, e.g., in
epithelial cells lining mucosal surfaces and in phagocytes),
for a review see: [37]. In most cases the interaction of
PAMP with PRR leads to the production of proinflammatory
cytokines and activation of inflammation reaction. However,
various pathogenic bacteria including P. gingivalis may
exploit the PRRs to undermine the bacterial killing, or use
them to enable protected entry routs to host defense cells
[120].
Complement system is the immediate and major
humoral component of innate immune response [121]. It is
activated immediately in the presence of a pathogen. The
action of the complement system aﬀects both innate and
adaptive immunity and thus has an important role in inflam-
matory and immune responses. The complement system is a
biochemical cascade of the small plasma proteins that acti-
vate another in series. Many of the complement proteins are
proteases. They are stored and secreted as inactive proen-
zymes. Normally they are distributed throughout the
body without adverse eﬀects. At site of infection proen-
zymes become proteases and produce local inflammatory
responses. There are three separate pathways of complement
activation. The pathways include the classical pathway, the
alternative pathway and the lectin-mediated pathway. The
alternative pathway is activated directly by bacteria-C3 inter-
action, and the classical pathway by the antigen-antibody
interaction with C4 [122–125]. The C3 fragment is impor-
tant in all three pathways. In the periodontal region T.
denticola has been shown to activate C3 by chymotrypsin like
protease dentilisin and P. gingivalis both C3 and C5 by
cysteine protease gingipain-1. This leads to formation of
C3a, C3b, and C5a [126, 127]. The C3b molecule opsonizes
pathogens and thus targets them to phagocytosis. C3a and
also C5a in turn act as chemoattractants for phagocytes and
activate mast cells. Mast cells contribute to the inflammatory
reaction by releasing histamine, inflammatory mediators and
cytokines such as leukotrienes. Mast cells show MMP-1, -2,
and -8 activity which is linked to periodontal tissue break-
down [128]. Furthermore, complement activation increases
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vascular permeability and attracts phagocytes to the inflam-
matory site. In the periodontal region complement proteins
and activation products have been detected in GCF and in
the periodontal tissues both in health and disease [123, 129–
131]. It has been suggested that complement deposits in
connective tissue may reflect disease-associated complement
activation [130]. Several activated complement components
form a membrane attack complex (MAC), which creates a
transmembrane pore leading to the lysis of the target cell and
may thus lead to destruction of both bacterial and host cells.
MAC inhibitor, CD59, is expressed in gingival epithelium
and thus gingival epithelium is probably well-protected
against MAC mediated cell damage [130]. Interestingly, the
action of periodontal bacteria on complement seems to be
biphasic. In addition to activation, periodontal pathogens
such as P. gingivalis andA. actinomycetemcomitansmay evade
human complement mediated killing. Gingipains are pro-
teases secreted by P. gingivalis. They degrade complement
proteins. Other P. gingivalis proteinases inactivate leukocyte
C5a receptor and A. actinomycetemcomitans serotype b
lipopolysaccharide fails to interact with complement-derived
opsonins [132–135]. In addition to the impaired pathogen-
mediated complement activation, a clinical study has found
partial gene deficiencies in complement C4 genes in patients
suﬀering from chronic recurring periodontal inflammation
[136]. C4 deficiencies have been previously associated with
chronic mucosal infections and the authors suggested that it
may also predispose to periodontal infections. However, the
role of complement in periodontal diseases still needs further
studies.
Precursors of the monocyte/macrophage lineage may
diﬀerentiate into macrophages, dendritic cells, or osteoclasts
[137]. Macrophages are eﬃcient phagocytes and are abun-
dant within the gingival tissues. They express TLRs that
interact with PAMPs (LPS, LTA, and PGN) and release proin-
flammatory cytokines (IL-1, TNF-alpha, IL-6, and IL-12)
and chemoattractants (e.g., IL-8). When diﬀerentiated into
dendritic cells macrophages participate in antigen presen-
tation by expressing costimulatory molecules and MHC-II
molecules [37]. Dendritic cells form the crucial link between
the innate and adaptive immunity. Langerin is a transmem-
brane cell surface protein which plays a role in antigen
recognition and uptake. Langerhans cells, identified by the
C-type lectin langerin, are dendritic cells responsible for the
presentation of antigens to T-lymphocytes. In healthy gin-
gival epithelium also large numbers of resident Langerin+
Langerhans cells have been found [137]. In periodontitis
their number decreases intraepithelially and increases in con-
nective tissue where antigen presentation takes place. The
cells of the monocyte/macrophage lineage are important for
the inflammatory reaction and also stand in the turning
point of the adaptive host response. In addition, when
diﬀerentiated to osteoclasts or via RANKL (receptor activator
of nuclear factor kappa B-ligand) activation the monocyte-
macrophage lineage cells also contribute to bone resorption
[137]. Hyperreactive monocyte/macrophage IL-1 genotype
has been connected to increased periodontal tissue destruc-
tion [138–140]. However, the connection between the IL-
1 gene polymorphism and the clinical manifestations of
Table 2: Innate and adaptive defense in the periodontal region.
Innate defense response Adaptive immune response
Epithelial barrier
Antigen presenting cells
MHC-I, MHC-II
PMNs, complement T helper 1 response
Monocyte/macrophage, mast cells T helper 2 response
Fibroblasts B cells, plasma cells
periodontal disease do not seem to be likewise certain in all
populations [141, 142].
5. The Role of the Specific (Adaptive) Immune
Defense in Host-Bacteria Crosstalk
The innate immune system is a crucial part of the defense at
the early stages of infection and further controls the emer-
gence of the adaptive immune response [143] (Table 2).
Periodontal pathogens may also evade or escape the innate
defense mechanisms and in such cases the cells of the adap-
tive immune response have an important role in recognizing
the pathogens and initiating specific defense targeted to the
pathogens involved. The key cells of the adaptive immune
defense are the T-lymphocytes (T-helper-1 (Th1), T-helper-2
(Th2), and T-killer-cells) and B-lymphocytes [144]. They
have receptors (T-cell receptor, TCR, and B cell antigen
receptor, BCR) on their surface that recognize and respond to
bacterial antigens. Bacterial antigens coupled with antigen
presenting cells with major histocompatibility complex
(MHC) class-I molecules are recognized by T-killer cells and
B cells. T-helper cells (Th1- and Th2-cells) recognize anti-
gens coupled to class II MHC molecules. The recognition of
the antigens in conjunction with costimulation with tumor
necrosis factor (TNF) molecules leads to activation of the
lymphocytes, production of the proinflammatory and/or
anti-inflammatory cytokines (respectively Th1:IFN-gamma,
IL-2, IL-12, and TNF-beta, Th2: IL-4, IL-5, IL-6 IL-10, and
IL-13) and/or antibodies (by B cells; plasma cells/memory B
cells). Both Immunoglobulin G and A (IgG and IgA) seem to
be important to periodontal defense and are found in
periodontal tissues and saliva [145–147]. During periodontal
disease progression the levels of IgG and IgA against A.
actinomycetemcomitans and P. gingivalis increase, and they
correlate with the existing periodontitis and pathogen car-
riage in saliva [146, 147].
Although the immune response is primarily aimed to
protect the host from the bacteria, it also seems to be
strongly involved in tissue destruction in the periodontal
region, Figure 1(c). Diﬀerent models of tissue protection and
destruction by the lymphocyte activation have been pro-
posed [148–150] and the role of the diﬀerent subsets of T-
lymphocytes at diﬀerent stages of the disease is still a matter
of question. The anti-inflammatory cytokine profile of the
Th2 response, low levels of costimulatory molecules and
B-cell dependent antibody production have been suggested
to dominate in cases of commensal bacteria, nonsuscep-
tible patients and protective immune response whereas
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Healthy dentogingival junction
-Rapid renewal of JE cells
-Gingival crevicular fluid flow
-Basement membranes 
-Antimicrobial peptides
-IL-8 and ICAM-1 gradient 
-PMN primary defense
(laminins 1 and 5)
in JE
(a)
Initiation of tissue destruction
-Increased permeability in JE
-Apoptosis of bacteria invaded cells
-Changes in cell division pattern?
-Changes in basement membranes?
-Antimicrobial peptides↑
-IL-8 and ICAM-1 gradient disappears
-IL-1, IL-6,  and TNF-alpha↑
-TLR-2, TLR-4↑
-Coronal degeneration and 
-Apical and lateral migration of JE
Bacteria
detachment of JE
-MMP-8, -9, and -1 activation in CT
(b)
Advanced tissue destruction
-Specific immune response
-RANKL-RANK binding and 
-Bone resorption
Bacteria
osteoclast activation
(c)
Figure 1: (a) Healthy dentogingival junction is an active part of the innate periodontal defense. (b) The epithelium and connective tissue
are aﬀected at the initial phase of periodontal tissue destruction. (c) In periodontitis the epithelial barrier is broken, bacteria may invade
the tissue (black spots), and connective tissue and bone are degraded. Junctional epithelium, dark red. Connective tissue and periodontal
ligament fibers green, and bone yellow. Bacteria black, pocket epithelium light gray. (a) Is a modified version of a figure from Po¨lla¨nen et al.
[112].
the periodontopathogenic bacteria are thought to trigger the
proinflammatory Th1 cytokine response resulting in inflam-
matory periodontal bone resorption [88, 149–151]. Th1
cells express on their surface RANKL capable to bind to
RANK on osteoclast precursor cells and thus directly induce
osteoclastic bone resorption [152, 153]. Alternatively the
cytokines produced by Th1 cells can indirectly lead to bone
resorption by inducing RANKL expression on osteoblasts
that can bind to RANK on osteoclast precursor cells and
activate osteoclast diﬀerentiation [150]. However, diﬀerent
models have also been proposed where the Th2 cell response
has been connected to periodontal bone destruction by
uncontrolled B-cell production of IL-1 or B-cell expression of
RANKL [152, 154]. Also osteoprotegerin (OPG), the known
decoy receptor for and inhibitor of RANKL may regulate
and protect the host from inflammatory bone resorption,
since interference with RANKL by systemic administration of
OPG has resulted in abrogation of periodontal bone resorp-
tion in a rat model [150]. Recent studies on humans have
also suggested that in chronic periodontitis tissues a marked
reduction in RANKL/OPG mRNA ratio may explain the
immune response dependent bone resorption [155, 156].
6. In Vitro Models Studying
Host-Microbe Interaction
Host-microbe interaction leading to periodontal pocket for-
mation is a complex process, involving the presence of patho-
genic bacterial biofilm as well as a susceptible host defense
system. Improved methods to detect bacteria in periodon-
tal biofilm have broadened our knowledge about pocket-
associated microbes. In spite of the wide range of innate
defense mechanisms at the dentogingival junction, the bac-
teria are able to surpass the host defense. Many of the peri-
odontal pathogens take advantage of the host defense and
thus enhance their growth in biofilm. It is clear that
degradation of periodontal connective tissue and bone due to
inflammation is an important part of the pocket formation.
However, the most coronal part of the JE attached to the
tooth appear to stand in first line of periodontal defense.
Yet surprisingly small number of studies has been done on
this early host-microbe interaction. The wide intercellular
spaces and permeability of the JE, even though beneficial for
the host defense, also allow bacteria and their harmful
products to penetrate epithelium, which thereby activate
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Metal
grid
Epithelium Connective
tissue
Medium
Tooth slice
Epithelial cell layer
Fibroblast-collagen matrix
S
(a)
Metal
grid
Layered
culture
Medium
Tooth slice
Epithelial cell layer
Fibroblast-collagen matrix
(b)
Figure 2: (a) A primary culture model for JE is formed when a piece of masticatory mucosa is placed on the top of a Millipore filter and
cultured for 7–10 days. The interface between the filter and the epithelium shows morphologically similar hemidesmosomal attachment as
the epithelium-tooth interface in vivo. Into this model planktonic bacteria or bacterial products can be added to the culture medium. (b)
Organotypic culture model of the JE can be accomplished by culturing fibroblasts in a collagen gel and seeding keratinocytes and placing a
piece of tooth on the top. Separately grown bacterial biofilms can be added onto the cultures. Cocultures with bacterial biofilms can be used
to study host-microbe interactions with this model.
Figure 3: Primary JE culture treated withA. actinomycetemcomitans
LPS shows migration of the epithelium into CT (arrows).
the inflammatory reaction. The initial events of periodontal
pocket formation are likely to involve destruction of the
dento-epithelial junction resulting in the failure of the
epithelial barrier function.
Monolayers of epithelial and connective tissue cells as
well as planktonic bacteria have been widely used in studies
on periodontal host-microbe interactions. Such experimen-
tal setups however lack important issues, for example, cell-
cell contacts of the multilayered epithelium, the basement
membranes and the epithelium-connective tissue interface as
well as the microbial pathogenicity of the biofilm. As stated
before in this paper, bacteria behave diﬀerently in biofilms,
where some virulence genes are expressed due to the quorum
sensing signaling. Diﬀerent models of periodontal multilayer
tissue cultures have been developed since the 1980s [157].
Two kinds of models have been used in our laboratory,
Figures 2(a) and 2(b). The primary tissue culture model of
JE Figure 2(a), in which a piece of masticatory mucosa is
placed on a permeable filter, allows studies, for example,
bacterial components on the dentogingival junction in vitro.
Figure 4: Organotypic culture model of the JE shows the structures
of the dentogingival junction, JE = in vitro junctional epithelium, T
= tooth, CT = connective tissue. When biofilm is placed on the top
of the model host-bacteria interaction can be studied.
Application of A. actinomycetemcomitans LPS into the cul-
ture medium has resulted in migration of the in vitro JE
into the CT, Figure 3. Although this model is a very delicate
and excellent model, it is diﬃcult to repeat and individual
variation may influence the results. The other model,
Figure 2(b), originally presented by Oksanen and Hormia
[158], uses cell lines of either oral or skin origin and further
includes a piece of tooth onto which the JE is formed
Figure 4. This model is easier to repeat and allows also the
placement of bacterial biofilms on top of the culture. With
this model F. nucleatum biofilm was shown to induce
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epithelial antimicrobial peptides human beta defensins 2 and
3 [159].
The organotypic tissue culture models are convenient
systems to study how periodontal pathogens penetrate not
only to the cells but also to the cell layers. A. actinomycetem-
comitans passes through the gingival cell layers quickly inter-
cellularly, whereas P. gingivalis invades the cell layer more
slowly by using also intracellular route [160]. In addition, the
biofilm mode of growth may alter the amount of cytokines,
such as IL-1β, also called as “the gatekeeper of inflammation”
for review see [161], in the host-bacterium contact site.
Planktonic cells of opportunistic periodontal pathogens A.
actinomycetemcomitans and F. nucleatum induce the IL-1β
production from gingival epithelial cell multilayers [160].
However, at least A. actinomycetemcomitans biofilm has the
capacity to bind and internalize IL-1β [162], which could
slow down the progression of inflammation and modify the
local microenvironment more favorable for bacterial growth.
7. Conclusions and Clinical Considerations
The host-microbe interaction at the dentogingival junction
may involve several detrimental mechanisms leading to
periodontal pocket formation.
7.1. Bacterial Enzymes Destroy the Dento-Epithelial Junction.
It is probably not a coincidence that some of the known
periodontopathogens, that is, P. gingivalis and T. denticola
have strong proteolytic enzymes capable of degrading all
the protein components as well as the proteins of cell
surface and the cell-cell junctions. Morphological studies
have shown that the IBL, can be detected on the tooth surface
in advanced periodontitis adjacent to degenerated DAT cells
[163]. However, this does not exclude the possibility that its
molecular structures may be altered. Certain MMPs from
eucaryotic cells are also able to cleave laminin-332, exposing
a cryptic molecular site that triggers cell migration [164].
7.2. The Activated Epithelium Secretes Enzymes Degrading
the Underlying Basement Membrane and Facilitates Epithelial
Growth to Connective Tissue. Many bacterial products and
cytokines are able to increase production ofMMPs by epithe-
lial cells. Since pathologically elevated levels of active MMPs
have been found in periodontal tissues during periodontitis,
the MMPs may play a role in lateral and apical migration of
the JE during pocket formation [95, 165].
7.3. Adhesion of the Infected Epithelium to Tooth Is Weakened.
As an example, HSP60 from A. actinomycetemcomitans has
been shown to decrease the number of epithelial basement
membrane binding integrin, α6β4 [166]. This receptor is
crucial for binding of JE to basement membrane. Absence
of another integrin, αvβ6, that activates TGF-beta, has been
suggested to play a part in the formation of periodontitis
[119].
7.4. PMNs Secrete Enzymes Degrading the Dentogingival
Junction. Many proteinases secreted by PMNs are capable of
degrading basal lamina components, including laminin 332
[112]. In already early periodontitis a great number of PMNs
are migrating through gingival epithelium.
7.5. Epithelial Cells of JE Undergo Degeneration and Apoptotic
or Toxic Death. Periodontopathogens producing short chain
fatty acids significantly impair the rapid renewal of the
coronal JE/DAT cells and thereby counteract one of the
tissues main host protective functions. Bacterial metabolites,
LTAs, LPSs, and other toxins are able to cause epithelial cell
death at high concentrations. Degeneration and detachment
of the DAT cells, loss of cellular continuity, and cell death
in the coronal part of the JE and development of an
intraepithelial split have been suggested in the initial phase of
periodontal pathology [167–170]. Studies have also reported
apoptosis in cells of pocket epithelium caused by bacterial
internalization [171] and enhanced activation of intracellular
proteases that regulate apoptosis (caspases 3 and 7) [172].
The crucial steps in the failure of the host defense are
the loss of the epithelial barrier function, the inflammation-
driven degradation of the connective tissue and osteoclast
activation via the imbalance of RANKL/OPG ratio. It has
become evident, that both insuﬃcient and exaggerated
inflammatory response, are detrimental to host. The inhib-
ited or exaggerated inflammatory response results from an
imbalance of pro- and anti-inflammatory cytokines.
Although periodontal pocket formation/periodontitis is
a pathologic process, we should keep in mind that, the
host response that causes the tissue destruction, is aimed
to restrict the spreading of the infection into deeper areas.
Despite of a huge number of studies on periodontitis
development, we still do not have a clear picture of the crucial
events leading to the periodontal tissue destruction. It is
obvious, however, that many factors, including direct bac-
terial eﬀects and response of the host cells are involved in
this process. Once these events are better understood treat-
ment modalities aiming at preventing periodontal pocket
formation can be designed. It should be emphasized, that
when treating periodontal disease, continuous control of the
infection should be the first goal, and only in addition to that,
modulation of the host response may be considered.
References
[1] A. D. Haﬀajee and S. S. Socransky, “Microbial etiological
agents of destructive periodontal diseases,” Periodontology
2000, vol. 5, pp. 78–111, 1994.
[2] R. J. Genco, “Consensus report on periodontal diseases:
pathogenesis and microbial factors,” in Annals of Periodon-
tology, R. J. Genco, Ed., pp. 926–932, American Academy of
Periodontology, Chicago, Ill, USA, 1996.
[3] S. S. Socransky and A. D. Haﬀajee, “Periodontal microbial
ecology,” Periodontology 2000, vol. 38, pp. 135–187, 2005.
[4] P. S. Kumar, A. L. Griﬀen, M. L. Moeschberger, and E. J. Leys,
“Identification of candidate periodontal pathogens and ben-
eficial species by quantitative 16S clonal analysis,” Journal of
Clinical Microbiology, vol. 43, no. 8, pp. 3944–3955, 2005.
[5] B. Zinsli Fritschi, A. Albert-Kiszely, and G. R. Persson,
“Staphylococcus aureus and other bacteria in untreated
International Journal of Dentistry 9
periodontitis,” Journal of Dental Research, vol. 87, no. 6, pp.
589–593, 2008.
[6] A. P. V. Colombo, S. K. Boches, S. L. Cotton et al., “Com-
parisons of subgingival microbial profiles of refractory peri-
odontitis, severe periodontitis, and periodontal health using
the human oral microbe identification microarray,” Journal
of Periodontology, vol. 80, no. 9, pp. 1421–1432, 2009.
[7] A. Ja¨rvensivu, J. Hietanen, R. Rautemaa, T. Sorsa, and M.
Richardson, “Candida yeasts in chronic periodontitis tissues
and subgingival microbial biofilms in vivo,” Oral Diseases,
vol. 10, no. 2, pp. 106–112, 2004.
[8] X. Song, E. R. K. Eribe, J. Sun, B. F. Hansen, and I.
Olsen, “Genetic relatedness of oral yeasts within and between
patients with marginal periodontitis and subjects with oral
health,” Journal of Periodontal Research, vol. 40, no. 6, pp.
446–452, 2005.
[9] A. D. Haﬀajee and S. S. Socransky, “Microbiology of perio-
dontal diseases: introduction,” Periodontology 2000, vol. 38,
pp. 9–12, 2005.
[10] J. Slots, “Herpesviruses in periodontal diseases,” Periodontol-
ogy 2000, vol. 38, pp. 33–62, 2005.
[11] A. E. Duran-Pinedo, B. Paster, R. Teles, and J. Frias-Lopez,
“Correlation network analysis applied to complex biofilm
communities,” PLoS ONE, vol. 6, no. 12, Article ID e28438,
2011.
[12] J. Frias-Lopez and A. Duran-Pinedo, “Eﬀect of periodontal
pathogens on the metatranscriptome of a healthy multi-
species biofilmmodel,” Journal of Bacteriology, vol. 194, no. 8,
pp. 2082–2095, 2012.
[13] V. Cogoni, A. Morgan-Smith, J. Christopher Fenno, H. F.
Jenkinson, and D. Dymock, “Treponema denticola chymo-
trypsin-like proteinase (CTLP) integrates spirochaetes within
oral microbial communities,” Microbiology, vol. 158, no. 3,
pp. 759–770, 2012.
[14] A. W. Aruni, F. Roy, and H. M. Fletcher, “Filifactor alocis has
virulence attributes that can enhance its persistence under
oxidative stress conditions and mediate invasion of epithelial
cells by Porphyromonas gingivalis,” Infection and Immunity,
vol. 79, no. 10, pp. 3872–3886, 2011.
[15] H. Shao and D. R. Demuth, “Quorum sensing regulation
of biofilm growth and gene expression by oral bacteria and
periodontal pathogens,” Periodontology 2000, vol. 52, no. 1,
pp. 53–67, 2010.
[16] G. Hajishengallis, S. Liang, M. A. Payne et al., “Low-abund-
ance biofilm species orchestrates inflammatory periodontal
disease through the commensal microbiota and comple-
ment,” Cell Host and Microbe, vol. 10, no. 5, pp. 497–506,
2011.
[17] J. I. Salonen, “Proliferative potential of the attached cells
of human junctional epithelium,” Journal of Periodontal Re-
search, vol. 29, no. 1, pp. 41–45, 1994.
[18] J. Oksanen, L. M. Sorokin, I. Virtanen, and M. Hormia, “The
junctional epithelium around murine teeth diﬀers from gin-
gival epithelium in its basement membrane composition,”
Journal of Dental Research, vol. 80, no. 12, pp. 2093–2097,
2001.
[19] M. Bickel, “The role of interleukin-8 in inflammation and
mechanisms of regulation,” Journal of Periodontology, vol. 64,
no. 5, pp. 456–460, 1993.
[20] J. M. Crawford, “Distribution of ICAM-1, LFA-3 and HLA-
DR in healthy and diseased gingival tissues,” Journal of
Periodontal Research, vol. 27, no. 4, pp. 291–298, 1992.
[21] N. Mukaida, A. Harada, K. Yasumoto, and K. Matsushima,
“Properties of pro-inflammatory cell types-specific leukocyte
chemotactic cytokinetis, interleukin 8(IL-8) and monocyte
chemotactic and activating factor (MCAF),” Microbiology
and Immunology, vol. 36, no. 8, pp. 773–789, 1992.
[22] M. S. Tonetti, M. A. Imboden, L. Gerber, N. P. Lang, J.
Laissue, and C. Mueller, “Localized expression of mRNA for
phagocyte-specific chemotactic cytokines in human peri-
odontal infections,” Infection and Immunity, vol. 62, no. 9,
pp. 4005–4014, 1994.
[23] B. A. Dale, “Periodontal epithelium: a newly recognized role
in health and disease,” Periodontology 2000, vol. 30, no. 1, pp.
70–78, 2002.
[24] M. Miyauchi, S. Sato, S. Kitagawa et al., “Cytokine expression
in rat molar gingival periodontal tissues after topical applica-
tion of lipopolysaccharide,” Histochemistry and Cell Biology,
vol. 116, no. 1, pp. 57–62, 2001.
[25] K. F. Ross and M. C. Herzberg, “Calprotectin expression by
gingival epithelial cells,” Infection and Immunity, vol. 69, no.
5, pp. 3248–3254, 2001.
[26] D. L. Diamond, J. R. Kimball, S. Krisanaprakornkit, T. Ganz,
and B. A. Dale, “Detection of β-defensins secreted by human
oral epithelial cells,” Journal of Immunological Methods, vol.
256, no. 1-2, pp. 65–76, 2001.
[27] M. Mathews, H. P. Jia, J. M. Guthmiller et al., “Production
of β-defensin antimicrobial peptides by the oral mucosa and
salivary glands,” Infection and Immunity, vol. 67, no. 6, pp.
2740–2745, 1999.
[28] Q. Lu, L. Jin, R. P. Darveau, and L. P. Samaranayake,
“Expression of human β-defensins-1 and -2 peptides in
unresolved chronic periodontitis,” Journal of Periodontal
Research, vol. 39, no. 4, pp. 221–227, 2004.
[29] T. Noguchi, H. Shiba, H. Komatsuzawa et al., “Syntheses of
prostaglandin E2 and E-cadherin and gene expression of β-
defensin-2 by human gingival epithelial cells in response to
actinobacillus actinomycetemcomitans,” Inflammation, vol.
27, no. 6, pp. 341–349, 2003.
[30] A. Vankeerberghen, H. Nuytten, K. Dierickx, M. Quirynen,
J. J. Cassiman, and H. Cuppens, “Diﬀerential induction of
human beta-defensin expression by periodontal commensals
and pathogens in periodontal pocket epithelial cells,” Journal
of Periodontology, vol. 76, no. 8, pp. 1293–1303, 2005.
[31] W. O. Chung, S. R. Hansen, D. Rao, and B. A. Dale, “Protease-
activated receptor signaling increases epithelial antimicrobial
peptide expression,” Journal of Immunology, vol. 173, no. 8,
pp. 5165–5170, 2004.
[32] K. Nisapakultorn, K. F. Ross, and M. C. Herzberg, “Calpro-
tectin expression in vitro by oral epithelial cells confers resis-
tance to infection by Porphyromonas gingivalis,” Infection
and Immunity, vol. 69, no. 7, pp. 4242–4247, 2001.
[33] U. K. Gursoy, E. Ko¨no¨nen, N. Luukkonen, and V. J. Uitto,
“Human neutrophil defensins and their eﬀect on epithelial
cells,” Journal of Periodontology. In press.
[34] V. J. Uitto, J. I. Salonen, J. D. Firth, H. Jousimies-Somer, and
U. Saarialho-Kere, “Matrilysin (matrix metalloproteinase-
7) expression in human junctional epithelium,” Journal of
Dental Research, vol. 81, no. 4, pp. 241–246, 2002.
[35] C. L. Wilson, A. J. Ouellette, D. P. Satchell et al., “Regulation
of intestinal α-defensin activation by the metalloproteinase
matrilysin in innate host defense,” Science, vol. 286, no. 5437,
pp. 113–117, 1999.
[36] Y. S. Lo´pez-Boado, C. L. Wilson, L. V. Hooper, J. I. Gordon,
S. J. Hultgren, and W. C. Parks, “Bacterial exposure induces
10 International Journal of Dentistry
and activates matrilysin in mucosal epithelial cells,” Journal
of Cell Biology, vol. 148, no. 6, pp. 1305–1315, 2000.
[37] P. N. Madianos, Y. A. Bobetsis, and D. F. Kinane, “Generation
of inflammatory stimuli: how bacteria set up inflammatory
responses in the gingiva,” Journal of Clinical Periodontology,
vol. 32, no. 6, pp. 57–71, 2005.
[38] T. Njoroge, R. J. Genco, H. T. Sojar, N. Hamada, and C.
A. Genco, “A role for fimbriae in Porphyromonas gingivalis
invasion of oral epithelial cells,” Infection and Immunity, vol.
65, no. 5, pp. 1980–1984, 1997.
[39] H. Loppnow, H. Brade, E. T. Rietschel, and H. D. Flad,
“Induction of cytokines in mononuclear and vascular cells by
endotoxin and other bacterial products,” Methods in Enzy-
mology, vol. 236, pp. 3–10, 1994.
[40] K. Monefeldt and T. Tollefsen, “Eﬀects of a streptococcal
lipoteichoic acid on complement activation in vitro,” Journal
of Clinical Periodontology, vol. 20, no. 3, pp. 186–192, 1993.
[41] S. Bhakdi, T. Klonisch, P. Nuber, andW. Fischer, “Stimulation
of monokine production by lipoteichoic acids,” Infection and
Immunity, vol. 59, no. 12, pp. 4614–4620, 1991.
[42] E. H. Beachey and W. A. Simpson, “The adherence of group
A streptococci to oropharyngeal cells: the lipoteichoic acid
adhesin and fibronectin receptor,” Infection, vol. 10, no. 2, pp.
107–111, 1982.
[43] S. C. Holt and T. E. Bramanti, “Factors in virulence expres-
sion and their role in periodontal disease pathogenesis,”
Critical Reviews in Oral Biology and Medicine, vol. 2, no. 2,
pp. 177–281, 1991.
[44] G. Ro¨lla, O. J. Iversen, and P. Bonesvoll, “Lipoteichoic acid—
the key to the adhesiveness of sucrose grown Streptococcus
mutans,” Advances in Experimental Medicine and Biology, vol.
107, pp. 607–617, 1978.
[45] M. T. Po¨lla¨nen, J. I. Salonen, D. Grenier, and V. J. Uitto,
“Epithelial cell response to challenge of bacterial lipoteichoic
acids and lipopolysaccharides in vitro,” Journal of Medical
Microbiology, vol. 49, no. 3, pp. 245–252, 2000.
[46] I. A. Bab, M. N. Sela, I. Ginsburg, and T. Dishon, “Inflam-
matory lesions and bone resorption induced in the rat
periodontium by lipoteichoic acid of Streptococcus mutans,”
Inflammation, vol. 3, no. 4, pp. 345–358, 1979.
[47] E. Hausmann, B. C. Nair, and R. Dziak, “Bacterial compo-
nents which result in bone loss,” inHos Parasite Interactions in
Periodontal Diseases, R. J. Genco and S. E.Merhagen, Eds., pp.
151–159, American Society for Microbiology, Washington,
DC, USA, 1982.
[48] D. N. Tatakis and P. S. Kumar, “Etiology and pathogenesis
of periodontal diseases,” Dental Clinics of North America, vol.
49, no. 3, pp. 491–516, 2005.
[49] A. L. Salzman, W. Hailong, P. S. Wollert et al., “Endotoxin-
induced ileal mucosal hyperpermeability in pigs: role of
tissue acidosis,” American Journal of Physiology, vol. 266, no.
4, pp. G633–G646, 1994.
[50] R. Snyderman, “Role for endotoxin and complement in peri-
odontal tissue destruction,” Journal of Dental Research, vol.
51, no. 2, pp. 356–361, 1972.
[51] P. M. Bartold, A. S. Narayanan, and R. C. Page, “Platelet-
derived growth factor reduces the inhibitory eﬀects of
lipopolysaccharide on gingival fibroblast proliferation,” Jour-
nal of Periodontal Research, vol. 27, no. 5, pp. 499–505, 1992.
[52] F. A. DeRenzis and S. Y. Chen, “Ultrastructural study of
cultured human gingival fibroblasts exposed to endotoxin,”
Journal of Periodontology, vol. 54, no. 2, pp. 86–90, 1983.
[53] S. J. Hill and J. L. Ebersole, “The eﬀect of lipopolysaccharide
on growth factor-induced mitogenesis in human gingival
fibroblasts,” Journal of Periodontology, vol. 67, no. 12, pp.
1274–1280, 1996.
[54] S. Kamin, W. Harvey, M. Wilson, and A. Scutt, “Inhibition
of fibroblast proliferation and collagen synthesis by capsular
material from Actinobacillus actinomycetemcomitans,” Jour-
nal of Medical Microbiology, vol. 22, no. 3, pp. 245–249, 1986.
[55] H. Larjava, V. J. Uitto, E. Eerola, and M. Haapasalo, “Inhibi-
tion of gingival fibroblast growth by Bacteroides gingivalis,”
Infection and Immunity, vol. 55, no. 1, pp. 201–205, 1987.
[56] D. L. Layman and D. L. Diedrich, “Growth inhibitory eﬀects
of endotoxins from Bacteroides gingivalis and intermedius
on human gingival fibroblasts in vitro,” Journal of Periodon-
tology, vol. 58, no. 6, pp. 387–392, 1987.
[57] T. Takata, M. Miyauchi, I. Ogawa, H. Ito, J. Kobayashi, and
H. Nikai, “Reactive change in proliferative activity of the
junctional epithelium after topical application of lipopoly-
saccharide,” Journal of Periodontology, vol. 68, no. 6, pp. 531–
535, 1997.
[58] B. Zhang, B. Wang, Y. Chen, J. Yang, and J. Zhang, “Influence
of lipopolysaccharide and interleukin-2 on proliferation
and synthesis of sulfated macromolecules in cultured rat
glomerular epithelial cells,” Chinese Medical Journal, vol. 109,
no. 8, pp. 609–614, 1996.
[59] C. Eftimiadi, S. Valente, S.Mangiante, P. E.Mangiante, and R.
Niederman, “Short chain fatty acids produced by anaerobic
bacteria inhibit adhesion and proliferation of periodontal
ligament fibroblasts,” Minerva Stomatologica, vol. 42, no. 11-
12, pp. 481–485, 1993.
[60] M. T. Po¨lla¨nen, D. O. Overman, and J. I. Salonen, “Bacterial
metabolites sodium butyrate and propionate inhibit epithe-
lial cell growth in vitro,” Journal of Periodontal Research, vol.
32, no. 3, pp. 326–334, 1997.
[61] R. E. Singer and B. A. Buckner, “Butyrate and propionate:
important components of toxic dental plaque extracts,” Infec-
tion and Immunity, vol. 32, no. 2, pp. 458–463, 1981.
[62] B. C. Sorkin and R. Niederman, “Short chain carboxylic
acids decrease human gingival keratinocyte proliferation and
increase apoptosis and necrosis,” Journal of Clinical Periodon-
tology, vol. 25, no. 4, pp. 311–315, 1998.
[63] R. E. Singer and B. A. Buckner, “Propionate and butyrate
induction of gingival inflammation in the beagle,” Journal of
Dental Research, vol. 59, abstract, 670, 1980.
[64] S. Urnowey, T. Ansai, V. Bitko, K. Nakayama, T. Takehara,
and S. Barik, “Temporal activation of anti- and pro-apoptotic
factors in human gingival fibroblasts infected with the peri-
odontal pathogen, Porphyromonas gingivalis: potential role
of bacterial proteases in host signalling,” BMC Microbiology,
vol. 6, article 26, 2006.
[65] S. Paju, F. Goulhen, S. Asikainen, D. Grenier, D. Mayrand,
and V. J. Uitto, “Localization of heat shock proteins in clini-
cal Actinobacillus actinomycetemcomitans strains and their
eﬀects on epithelial cell proliferation,” FEMS Microbiology
Letters, vol. 182, no. 2, pp. 231–235, 2000.
[66] G. N. Belibasakis, M. Brage, T. Lagerga˚rd, and A. Johansson,
“Cytolethal distending toxin upregulates RANKL expression
in Jurkat T-cells,” Acta Pathologica, Microbiologica et Im-
munologica, vol. 116, no. 6, pp. 499–506, 2008.
[67] T. J. van Steenbergen, L. M. van der Mispel, and J. de Graaﬀ,
“Eﬀects of ammonia and volatile fatty acids produced by oral
bacteria on tissue culture cells,” Journal of Dental Research,
vol. 65, no. 6, pp. 909–912, 1986.
[68] K. Helgeland, “Inhibitory eﬀect of NH4Cl on secretion of
collagen in human gingival fibroblasts,” Scandinavian Journal
of Dental Research, vol. 92, no. 5, pp. 419–425, 1984.
International Journal of Dentistry 11
[69] O. M. Carro, S. A. S. Evans, and C. W. Leone, “Eﬀect of
inflammation on the proliferation of human gingival epithe-
lial cells in vitro,” Journal of Periodontology, vol. 68, no. 11,
pp. 1070–1075, 1997.
[70] L. Vitkov, W. D. Krautgartner, and M. Hannig, “Bacterial
internalization in periodontitis,” Oral Microbiology and Im-
munology, vol. 20, no. 5, pp. 317–321, 2005.
[71] E. Andrian, D. Grenier, and M. Rouabhia, “In vitro models
of tissue penetration and destruction by Porphyromonas
gingivalis,” Infection and Immunity, vol. 72, no. 8, pp. 4689–
4698, 2004.
[72] D. Ekuni, T. Tomofuji, R. Yamanaka, K. Tachibana, T.
Yamamoto, and T. Watanabe, “Initial apical migration of
junctional epithelium in rats following application of lipo-
polysaccharide and proteases,” Journal of Periodontology, vol.
76, no. 1, pp. 43–48, 2005.
[73] L. Ren, W. K. Leung, R. P. Darveau, and L. Jin, “The expres-
sion profile of lipopolysaccharide-binding protein, mem-
brane-bound CD14, and toll-like receptors 2 and 4 in chronic
periodontitis,” Journal of Periodontology, vol. 76, no. 11, pp.
1950–1959, 2005.
[74] A. Uehara, K. Muramoto, H. Takada, and S. Sugawara,
“Neutrophil serine proteinases activate human nonepithelial
cells to produce inflammatory cytokines through protease-
activated receptor 2,” Journal of Immunology, vol. 170, pp.
5690–5696, 2003.
[75] L. A. Abraham, C. Chinni, A. L. Jenkins et al., “Expression of
protease-activated receptor-2 by osteoblasts,” Bone, vol. 26,
no. 1, pp. 7–14, 2000.
[76] A. Lourbakos, J. Potempa, J. Travis et al., “Arginine-specific
protease from Porphyromonas gingivalis activates protease-
activated receptors on human oral epithelial cells and induces
interleukin-6 secretion,” Infection and Immunity, vol. 69, no.
8, pp. 5121–5130, 2001.
[77] R. P. Darveau, C. M. Belton, R. A. Reife, and R. J. Lamont,
“Local chemokine paralysis, a novel pathogenic mechanism
for porphyromonas gingivalis,” Infection and Immunity, vol.
66, no. 4, pp. 1660–1665, 1998.
[78] G. T. J. Huang, D. Kim, J. K. H. Lee, H. K. Kuramitsu, and
S. Kinder, “Interleukin-8 and intercellular adhesion molecule
1 regulation in oral epithelial cells by selected periodontal
bacteria: multiple eﬀects of Porphyromonas gingivalis via
antagonistic mechanisms,” Infection and Immunity, vol. 69,
no. 3, pp. 1364–1372, 2001.
[79] M. Holzhausen, L. C. Spolidorio, and N. Vergnolle, “Pro-
teinase-activated receptor-2 (PAR2) agonist causes periodon-
titis in rats,” Journal of Dental Research, vol. 84, no. 2, pp.
154–159, 2005.
[80] J. J. Reynolds, “Collagenases and tissue inhibitors of metallo-
proteinases: a functional balance in tissue degradation,” Oral
Diseases, vol. 2, no. 1, pp. 70–76, 1996.
[81] L. Hakkinen, J. Heino, L. Kiovisto, and H. Larjava, “Altered
interaction of human granulation-tissue fibroblasts with
fibronectin is regulated α5β1 integrin,” Biochimica et Bio-
physica Acta, vol. 1224, no. 1, pp. 33–42, 1994.
[82] L. Ha¨kkinen and H. Larjava, “Characterization of fibroblast
clones from periodontal granulation tissue in vitro,” Journal
of Dental Research, vol. 71, no. 12, pp. 1901–1907, 1992.
[83] R. C. Page and H. E. Schroeder, “Pathogenesis of inflam-
matory periodontal disease: a summary of current work,”
Laboratory Investigation, vol. 34, no. 3, pp. 235–249, 1976.
[84] D. F. Kinane and J. Lindhe, “Pathogenesis of periodontitis,”
in Clinical Periodontology and Implant dentistry, J. Lindhe,
T. Karring, and N. P. lang, Eds., pp. 189–225, Munksgaard,
Copenhagen, Denmark, 1997.
[85] A. Beklen, M. Ainola, M. Hukkanen, C. Gu¨rgan, T. Sorsa, and
Y. T. Konttinen, “MMPs, IL-1, and TNF are regulated by IL-
17 in periodontitis,” Journal of Dental Research, vol. 86, no. 4,
pp. 347–351, 2007.
[86] H. Domeij, T. Mode´er, and T. Yucel-Lindberg, “Matrix
metalloproteinase-1 and tissue inhibitor of metalloprotein-
ase-1 production in human gingival fibroblasts: the role of
protein kinase C,” Journal of Periodontal Research, vol. 39, no.
5, pp. 308–314, 2004.
[87] J. J. Reynolds and M. C. Meikle, “Mechanisms of connective
tissue matrix destruction in periodontitis,” Periodontology
2000, vol. 1997, no. 14, pp. 144–157, 1997.
[88] Z. Feng and A. Weinberg, “Role of bacteria in health and
disease of periodontal tissues,” Periodontology 2000, vol. 40,
no. 1, pp. 50–76, 2006.
[89] J. Carlsson, B. F. Herrmann, J. F. Hofling, and G. K.
Sundqvist, “Degradation of the human proteinase inhibitors
alpha-1-antitrypsin and alpha-2-macroglobulin by Bac-
teroides gingivalis,” Infection and Immunity, vol. 43, no. 2, pp.
644–648, 1984.
[90] L. Sandholm, “Proteases and their inhibitors in chronic in-
flammatory periodontal disease,” Journal of Clinical Peri-
odontology, vol. 13, no. 1, pp. 19–26, 1986.
[91] T. Nilsson, J. Carlsson, and G. Sundqvist, “Inactivation of key
factors of the plasma proteinase cascade systems by Bac-
teroides gingivalis,” Infection and Immunity, vol. 50, no. 2, pp.
467–471, 1985.
[92] D. Nelson, J. Potempa, T. Kordula, and J. Travis, “Purifica-
tion and characterization of a novel cysteine proteinase
(periodontain) from Porphyromonas gingivalis: evidence for
a role in the inactivation of human α1-proteinase inhibitor,”
Journal of Biological Chemistry, vol. 274, no. 18, pp. 12245–
12251, 1999.
[93] H. Birkedal-Hansen, “Role of cytokines and inflammatory
mediators in tissue destruction,” Journal of Periodontal Re-
search, vol. 28, no. 6, pp. 500–510, 1993.
[94] T. Kubota, T. Nomura, T. Takahashi, and K. Hara, “Expres-
sion of mRNA for matrix metalloproteinases and tissue
inhibitors of metalloproteinases in periodontitis-aﬀected
human gingival tissue,” Archives of Oral Biology, vol. 41, no.
3, pp. 253–262, 1996.
[95] Y. T. Teng, J. Sodek, and C. A. McCulloch, “Gingival crevicu-
lar fluid gelatinase and its relationship to periodontal disease
in human subjects,” Journal of Periodontal Research, vol. 27,
no. 5, pp. 544–552, 1992.
[96] M. Soell, R. Elkaim, and H. Tenenbaum, “Cathepsin C,
matrix metalloproteinases, and their tissue inhibitors in gin-
giva and gingival crevicular fluid from periodontitis-aﬀect-
ed patients,” Journal of Dental Research, vol. 81, no. 3, pp.
174–178, 2002.
[97] T. Sorsa, L. Tja¨derhane, and T. Salo, “Matrix metallopro-
teinases (MMPs) in oral diseases,” Oral Diseases, vol. 10, no.
6, pp. 311–318, 2004.
[98] M. Hernandez, M. A. Valenzuela, C. Lopez-Otin et al.,
“Matrix metalloproteinase-13 is highly expressed in destruc-
tive periodontal disease activity,” Journal of Periodontology,
vol. 77, no. 11, pp. 1863–1870, 2006.
[99] M. Ma¨kela¨, T. Salo, V. J. Uitto, and H. Larjava, “Matrix
metalloproteinases (MMP-2 and MMP-9) of the oral cavity:
cellular origin and relationship to periodontal status,” Journal
of Dental Research, vol. 73, no. 8, pp. 1397–1406, 1994.
12 International Journal of Dentistry
[100] V. J. Uitto, C. M. Overall, and C. McCulloch, “Proteolytic
host cell enzymes in gingival crevice fluid,” Periodontology
2000, vol. 31, pp. 77–104, 2003.
[101] P. Pozo, M. A. Valenzuela, C. Melej et al., “Longitudinal anal-
ysis of metalloproteinases, tissue inhibitors of metallopro-
teinases and clinical parameters in gingival crevicular fluid
from periodontitis-aﬀected patients,” Journal of Periodontal
Research, vol. 40, no. 3, pp. 199–207, 2005.
[102] M. Lorencini, J. A. F. Silva, C. A. Almeida, A. Bruni-Cardoso,
H. F. Carvalho, and D. R. Stach-Machado, “A new paradigm
in the periodontal disease progression: gingival connective
tissue remodeling with simultaneous collagen degradation
and fibers thickening,” Tissue and Cell, vol. 41, no. 1, pp. 43–
50, 2009.
[103] R. Attstro¨m, “Studies on neutrophil polymorphonuclear
leukocytes at the dento-gingival junction in gingival health
and disease,” Journal of Periodontal Research, vol. 8, supple-
ment, pp. 1–15, 1971.
[104] P. R. Garant, “Plaque: neutrophil interaction in monoin-
fected rats as visualized by transmission electron micro-
scopy,” Journal of Periodontology, vol. 47, no. 3, pp. 132–138,
1976.
[105] J. B. Matthews, H. J. Wright, A. Roberts, N. Ling-Mountford,
P. R. Cooper, and I. L. C. Chapple, “Neutrophil hyper-res-
ponsiveness in periodontitis,” Journal of Dental Research, vol.
86, no. 8, pp. 718–722, 2007.
[106] T. Sorsa, K. Suomalainen, and V. J. Uitto, “The role of
gingival crevicular fluid and salivary interstitial collagenases
in human periodontal diseases,” Archives of Oral Biology, vol.
35, no. 1, pp. S193–S196, 1990.
[107] P. Visca, F. Berlutti, P. Vittorioso, C. Dalmastri, M. C. Thaller,
and P. Valenti, “Growth and adsorption of Streptococcus
mutans 6715-13 to hydroxyapatite in the presence of lacto-
ferrin,” Medical Microbiology and Immunology, vol. 178, no.
2, pp. 69–79, 1989.
[108] R. M. Wilson and W. G. Reeves, “Neutrophil phagocytosis
and killing in insulin-dependent diabetes,” Clinical and Ex-
perimental Immunology, vol. 63, no. 2, pp. 478–484, 1986.
[109] L. C. Altman, C. Baker, P. Fleckman, D. Luchtel, and D. Oda,
“Neutrophil-mediated damage to human gingival epithelial
cells,” Journal of Periodontal Research, vol. 27, no. 1, pp. 70–
79, 1992.
[110] D. K. Dennison and T. E. VanDyke, “The acute inflammatory
response and the role of phagocytic cells in periodontal
health and disease,” Periodontology 2000, vol. 1997, no. 14,
pp. 54–78, 1997.
[111] J. Carlsson, “Growth and nutrition as ecological factors,” in
Oral Bacterial Ecology: The Molecular Basis, H. Kuramitsu
and R. Ellen, Eds., pp. 67–130, Horizon Scientific Press,
Norfolk, Va, USA, 2000.
[112] M. T. Po¨lla¨nen, J. I. Salonen, and V. J. Uitto, “Structure and
function of the tooth-epithelial interface in health and
disease,” Periodontology 2000, vol. 31, pp. 12–31, 2003.
[113] L. M. Golub, H. M. Lee, R. A. Greenwald et al., “A matrix
metalloproteinase inhibitor reduces bone-type collagen de-
gradation fragments and specific collagenases in gingival
crevicular fluid during adult periodontitis,” Inflammation
Research, vol. 46, no. 8, pp. 310–319, 1997.
[114] P. Permpanich, M. J. Kowolik, and D. M. Galli, “Resistance of
fluorescent-labelled Actinobacillus actinomycetemcomitans
strains to phagocytosis and killing by human neutrophils,”
Cellular Microbiology, vol. 8, no. 1, pp. 72–84, 2006.
[115] R. K. Liu, C. F. Cao, H. X. Meng, and Y. Gao, “Poly-
morphonuclear neutrophils and their mediators in gingival
tissues from generalized aggressive periodontitis,” Journal of
Periodontology, vol. 72, no. 11, pp. 1545–1553, 2001.
[116] A. Gu¨ntsch, M. Erler, P. M. Preshaw, B. W. Sigusch, G.
Klinger, and E. Glockmann, “Eﬀect of smoking on crevicular
polymorphonuclear neutrophil function in periodontally
healthy subjects,” Journal of Periodontal Research, vol. 41, no.
3, pp. 184–188, 2006.
[117] A. Gustafsson, H. Ito, B. A˚sman, and K. Bergstro¨m, “Hyper-
reactive mononuclear cells and neutrophils in chronic peri-
odontitis,” Journal of Clinical Periodontology, vol. 33, no. 2,
pp. 126–129, 2006.
[118] E. A. Nicu, U. VanDer Velden, V. Everts, A. J. VanWinkelhoﬀ,
D. Roos, and B. G. Loos, “Hyper-reactive PMNs in FcγRIIa
131 H/H genotype periodontitis patients,” Journal of Clinical
Periodontology, vol. 34, no. 11, pp. 938–945, 2007.
[119] F. Ghannad, D. Nica, M. I. Garcia Fulle et al., “Absence of
αvβ6 integrin is linked to initiation and progression of perio-
dontal disease,” American Journal of Pathology, vol. 172, no.
5, pp. 1271–1286, 2008.
[120] G. Hajishengallis and J. D. Lambris, “Microbial manipulation
of receptor crosstalk in innate immunity,” Nature Reviews
Immunology, vol. 11, no. 3, pp. 187–200, 2011.
[121] H. Rus, C. Cudrici, and F. Niculescu, “The role of the com-
plement system in innate immunity,” Immunologic Research,
vol. 33, no. 2, pp. 103–112, 2005.
[122] R. Attstrom, A. B. Laurel, U. Lahsson, and A. Sjoholm, “Com-
plement factors in gingival crevice material from healthy and
inflamed gingiva in humans,” Journal of Periodontal Research,
vol. 10, no. 1, pp. 19–27, 1975.
[123] H. A. Schenkein and R. J. Genco, “Gingival fluid and serum in
periodontal diseases. I. Quantitative study of immunoglobu-
lins, complement components, and other plasma proteins,”
Journal of Periodontology, vol. 48, no. 2, pp. 772–777, 1977.
[124] H. A. Schenkein and R. J. Genco, “Gingival fluid and serum in
periodontal diseases. II. Evidence for cleavage of complement
components C3, C3 proactivator (factor B) and C4 in
gingival fluid,” Journal of Periodontology, vol. 48, no. 2, pp.
778–784, 1977.
[125] K. Monefeldt, K. Helgeland, and T. Tollefsen, “In vitro
cleavage of serum complement protein C3: a comparison
between patients with adult periodontitis and periodontally
healthy persons,” Journal of Clinical Periodontology, vol. 22,
no. 1, pp. 45–51, 1995.
[126] J. A. Wingrove, R. G. DiScipio, Z. Chen, J. Potempa, J. Travis,
and T. E. Hugli, “Activation of complement components C3
and C5 by a cysteine proteinase (gingipain-1) from Por-
phyromonas (Bacteroides) gingivalis,” Journal of Biological
Chemistry, vol. 267, no. 26, pp. 18902–18907, 1992.
[127] T. Yamazaki, M. Miyamoto, S. Yamada, K. Okuda, and K.
Ishihara, “Surface protease of Treponema denticola hydro-
lyzes C3 and influences function of polymorphonuclear
leukocytes,” Microbes and Infection, vol. 8, no. 7, pp. 1758–
1763, 2006.
[128] E. P. Næsse, O. Schreurs, K. Helgeland, K. Schenck, and S.
Steinsvoll, “Matrix metalloproteinases and their inhibitors
in gingival mast cells in persons with and without human
immunodeficiency virus infection,” Journal of Periodontal
Research, vol. 38, no. 6, pp. 575–582, 2003.
[129] M. R. Patters, C. E. Niekrash, and N. P. Lang, “Assessment of
complement cleavage in gingival fluid during experimental
gingivitis in man,” Journal of Clinical Periodontology, vol. 16,
no. 1, pp. 33–37, 1989.
[130] R. Rautemaa and S. Meri, “Protection of gingival epithe-
lium against complement-mediated damage by strong
International Journal of Dentistry 13
expression of the membrane attack complex inhibitor pro-
tectin (CD59),” Journal of Dental Research, vol. 75, no. 1, pp.
568–574, 1996.
[131] M. S. Tonetti, “Molecular factors associated with com-
partmentalization of gingival immune responses and tran-
sepithelial neutrophil migration,” Journal of Periodontal Re-
search, vol. 32, no. 1, pp. 104–109, 1997.
[132] M. A. Jagels, J. A. Ember, J. Travis, J. Potempa, R. Pike, and
T. E. Hugli, “Cleavage of the human C5a receptor by pro-
teinases derived from porphyromonas gingivalis: cleavage of
leukocyte C5a Receptor,” Advances in Experimental Medicine
and Biology, vol. 389, pp. 155–164, 1996.
[133] N. Yamaguchi, H. Tsuda, Y. Yamashita, and T. Koga, “Bind-
ing of the capsule-like serotype-specific polysaccharide anti-
gen and the lipopolysaccharide from Actinobacillus actino-
mycetemcomitans to human complement-derived opso-
nins,” Oral Microbiology and Immunology, vol. 13, no. 6, pp.
348–354, 1998.
[134] T. Imamura, J. Travis, and J. Potempa, “The biphasic
virulence activities of gingipains: activation and inactivation
of host proteins,” Current Protein and Peptide Science, vol. 4,
no. 6, pp. 443–450, 2003.
[135] K. Popadiak, J. Potempa, K. Riesbeck, and A. M. Blom,
“Biphasic eﬀect of gingipains fromPorphyromonas gingivalis
on the human complement system,” Journal of Immunology,
vol. 178, no. 11, pp. 7242–7250, 2007.
[136] M. Seppa¨nen, M. L. Lokki, I. L. Notkola et al., “Complement
and C4 null alleles in severe chronic adult periodontitis,”
Scandinavian Journal of Immunology, vol. 65, no. 2, pp. 176–
181, 2007.
[137] C. W. Cutler and Y. T. A. Teng, “Oral mucosal dendritic cells
and periodontitis: many sides of the same coin with new
twists,” Periodontology 2000, vol. 45, no. 1, pp. 35–50, 2007.
[138] K. S. Kornman, “The interleukin-1 genotype as a severity
factor in adult periodontal disease,” Journal of Clinical Perio-
dontology, vol. 24, no. 1, pp. 72–77, 1997.
[139] K. S. Kornman and F. S. di Giovine, “Genetic variations in
cytokine expression: a risk factor for severity of adult perio-
dontitis,” Annals of Periodontology, vol. 3, no. 1, pp. 327–338,
1998.
[140] T. C. Hart and K. S. Kornman, “Genetic factors in the patho-
genesis of periodontitis,” Periodontology 2000, vol. 1997, no.
14, pp. 202–215, 1997.
[141] G. Greenstein and T. C. Hart, “Clinical utility of a genetic
susceptibility test for severe chronic periodontitis: a critical
evaluation,” Journal of the American Dental Association, vol.
133, no. 4, pp. 452–459, 2002.
[142] G. Greenstein and T. C. Hart, “A critical assessment of inter-
leukin-1 (IL-1) genotyping when used in a genetic suscep-
tibility test for severe chronic periodontitis,” Journal of Perio-
dontology, vol. 73, no. 2, pp. 231–247, 2002.
[143] Y. T. A. Teng, “Protective and destructive immunity in the
periodontium—part 1—innate and humoral immunity and
the periodontium,” Journal of Dental Research, vol. 85, no. 3,
pp. 198–208, 2006.
[144] P. Kidd, “Th1/Th2 balance: the hypothesis, its limitations,
and implications for health and disease,” AlternativeMedicine
Review, vol. 8, no. 3, pp. 223–246, 2003.
[145] D. F. Kinane and D. F. Lappin, “Immune processes in
periodontal disease: a review,” Annals of Periodontology, vol.
7, no. 1, pp. 62–71, 2002.
[146] M. H. Napimoga, L. H. A. C. Nunes, A. A. B. Maciel et al.,
“Possible Involvement of IL-21 and IL-10 on Salivary IgA
Levels in Chronic Periodontitis Subjects,” Scandinavian Jour-
nal of Immunology, vol. 74, no. 6, pp. 596–602, 2011.
[147] P. J. Pussinen, E. Ko¨no¨nen, S. Paju et al., “Periodontal patho-
gen carriage, rather than periodontitis, determines the serum
antibody levels,” Journal of Clinical Periodontology, vol. 38,
no. 5, pp. 405–411, 2011.
[148] E. Gemmell, K. Yamazaki, and G. J. Seymour, “Destructive
periodontitis lesions are determined by the nature of the
lymphocytic response,” Critical Reviews in Oral Biology and
Medicine, vol. 13, no. 1, pp. 17–34, 2002.
[149] K. Yamazaki, H. Yoshie, and G. J. Seymour, “T cell regulation
of the immune response to infection in periodontal diseases,”
Histology and Histopathology, vol. 18, no. 3, pp. 889–896,
2003.
[150] M. A. Taubman, P. Valverde, X. Han, and T. Kawai, “Immune
response: they key to bone resorption in periodontal disease,”
Journal of Periodontology, vol. 76, no. 11, pp. 2033–2041,
2005.
[151] Y. T. A. Teng, “Protective and destructive immunity in the
periodontium—part 2—T-cell-mediated immunity in the
periodontium,” Journal of Dental Research, vol. 85, no. 3, pp.
209–219, 2006.
[152] Y. Choi, K. M. Woo, S.-H. Ko, Y. J. Lee, S.-J. Park, and H.-
M. Kim, “Osteoclastogenesis is enhanced by activated B cells
but suppressed by activated CD8+ T cells,” European Journal
of Immunology, vol. 31, no. 7, pp. 2179–2188, 2001.
[153] Y. Y. Kung, U. Felge, I. Sarosi et al., “Activated T cells regulate
bone loss and joint destruction in adjuvant arthritis through
osteoprotegerin ligand,” Nature, vol. 402, no. 6759, pp. 304–
309, 1999.
[154] G. J. Seymour and E. Gemmell, “Cytokines in periodontal
disease: where to from here?” Acta Odontologica Scandinav-
ica, vol. 59, no. 3, pp. 167–173, 2001.
[155] D. L. Cochran, “Inflammation and bone loss in periodontal
disease,” Journal of Periodontology, vol. 79, no. 8, pp. 1569–
1576, 2008.
[156] N. Wara-Aswapati, R. Surarit, A. Chayasadom, J. A. Boch,
and W. Pitiphat, “RANKL upregulation associated with per-
iodontitis and porphyromonas gingivalis,” Journal of Peri-
odontology, vol. 78, no. 6, pp. 1062–1069, 2007.
[157] J. I. Salonen, M. B. Kautsky, and B. A. Dale, “Changes in cell
phenotype during regeneration of junctional epithelium of
human gingiva in vitro,” Journal of Periodontal Research, vol.
24, no. 6, pp. 370–377, 1989.
[158] J. Oksanen and M. Hormia, “An organotypic in vitro
model that mimics the dento-epithelial junction,” Journal of
Periodontology, vol. 73, no. 1, pp. 86–93, 2002.
[159] U. K. Gursoy, M. Po¨lla¨nen, E. Ko¨no¨nen, and V.-J. Uitto, “A
novel organotypic dento-epithelial culture model: eﬀect of
fusobacterium nucleatum biofilm on B-defensin-2, -3, and
LL-37 expression,” Journal of Periodontology, vol. 83, no. 2,
pp. 242–247, 2012.
[160] B. C. Dickinson, C. E. Moﬀatt, D. Hagerty et al., “Interaction
of oral bacteria with gingival epithelial cell multilayers,”
Molecular Oral Microbiology, vol. 26, no. 3, pp. 210–220,
2011.
[161] C. A. Dinarello, “A clinical perspective of IL-1β as the gate-
keeper of inflammation,” European Journal of Immunology,
vol. 41, no. 5, pp. 1203–1217, 2011.
[162] A. Paino, H. Tuominen, M. Ja¨a¨skela¨inen et al., “Trimeric
form of intracellular ATP synthase subunit β of aggregat-
ibacter actinomycetemcomitans binds human interleukin-
1β,” PLoS ONE, vol. 6, no. 4, Article ID e18929, 2011.
14 International Journal of Dentistry
[163] D. O. Overman and J. I. Salonen, “Characterization of the
human junctional epithelial cells directly attached to the
tooth (DAT cells) in periodontal disease,” Journal of Dental
Research, vol. 73, no. 12, pp. 1818–1823, 1994.
[164] G. Giannelli, J. Falk-Marzillier, O. Schiraldi, W. G. Stetler-
Stevenson, and V. Quaranta, “Induction of cell migration by
matrix metalloprotease-2 cleavage of laminin-5,” Science, vol.
277, no. 5323, pp. 225–228, 1997.
[165] V. J. Uitto, K. Airola, M. Vaalamo et al., “Collagenase-3
(matrix metalloproteinase-13) expression is induced in oral
mucosal epithelium during chronic inflammation,”American
Journal of Pathology, vol. 152, no. 6, pp. 1489–1499, 1998.
[166] L. Zhang, L. Koivisto, J. Heino, and V. J. Uitto, “Bacterial heat
shock protein 60 may increase epithelial cell migration
through activation of MAP kinases and inhibition of α6β4
integrin expression,” Biochemical and Biophysical Research
Communications, vol. 319, no. 4, pp. 1088–1095, 2004.
[167] S. Schluger, “Periodontics today: dentistry tomorrow,” Dis-
trict of Columbia Dental Society Journal, pp. 6–8, 1977.
[168] H. E. Schroeder and M. A. Listgarten, “The gingival tissues:
the architecture of periodontal protection,” Periodontology
2000, vol. 14, no. 1, pp. 91–120, 1997.
[169] T. Takata and K. Donath, “The mechanism of pocket forma-
tion. A light microscopic study on undecalcified human
material,” Journal of Periodontology, vol. 59, no. 4, pp. 215–
221, 1988.
[170] D. D. Bosshardt and N. P. Lang, “The junctional epithelium:
from health to disease,” Journal of Dental Research, vol. 84,
no. 1, pp. 9–20, 2005.
[171] L. Vitkov, W. D. Krautgartner, and M. Hannig, “Surface
morphology of pocket epithelium,”Ultrastructural Pathology,
vol. 29, no. 2, pp. 121–127, 2005.
[172] H. Bantel, T. Beikler, T. F. Flemmig, and K. Schulze-Osthoﬀ,
“Caspase activation is involved in chronic periodontitis,”
FEBS Letters, vol. 579, no. 25, pp. 559–5564, 2005.
Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oral Oncology
Journal of
Dentistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Biomaterials
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Case Reports in 
Dentistry
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oral Implants
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Anesthesiology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Radiology 
Research and Practice
Environmental and 
Public Health
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Dental Surgery
Journal of
Drug Delivery
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oral Diseases
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Pain
Research and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Preventive Medicine
Advances in
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Orthopedics
Advances in
